Resume

Sign in

University Medical

Location:
Chennai, Tamil Nadu, India
Salary:
1,00,000/pm
Posted:
October 31, 2016

Contact this candidate

Curriculum Vitae

Dr. Shilpa Devasenapathy, Ph.D.,

Technical Director

Virtis Bio Labs 39 / 3A2, Easwari Garden,

Kesavan Nagar, Kannankurichi,

Salem – 636 008, Tamil Nadu, India

Email: acxbcr@r.postjobfree.com

Mobile No: +919597926827

Academic Qualifications:

Sl. No.

Institution Place

Degree Awarded

Year

Field of Study

1

University of Madras

Ph.D

2007

Applied Microbiology Biochemistry

2

Kandasamy Kandars College, Velur, Tamil Nadu

M.Sc

2000

Applied Microbiology

3

Vysya College, Salem,

Tamil Nadu

B.Sc

1998

Microbiology

Work experience:

Sl. No.

Name of the Institution

Position

From

(Date)

To (Date)

1

Virtis Bio Labs Pvt. Ltd

Technical Director

Nov 2013

Till date

2

University of Malaya, Malaysia

Senior researcher

Aug 2010

Dec 2011

3

Sathyabama University

Senior Lecturer

June 2005

March 2010

Awards and Honors:

Principal Investigator, Rapid Grant Young investigator award by Department of Biotechnology, India (Amount funded: Rs. 12.8 lakhs), 2010.

“Studies on expression of OCT 4, SOX2, NANOG and FOXD3 genes in UV induced skin carcinogenesis in zebra fish embryos”.

Selected among Top 50 innovator in DST-LOCKHEED MARTIN IIGP 2014 and ranked 34th in the competition held in FICCI, New Delhi.

Received consolation prize from Society for Free Radical Research (SFRR) India satellite meet in 2007. P. N. Shilpa and S. Niranjali Devaraj. “Anti-invasive activity of Rubia cordifolia in Diethyl nitrosamine rats”.

Fellowships / Scholarships:

2010-2011: Postdoctoral fellowship, University of Malaya, Kuala Lumpur, Malaysia

Products Patent:

3200/CHE/2014 - Composition and method for biofilm prevention on dental surface

Publications:

1.Sivaramakrishnan, Shilpa PN, Praveenkumar VR and Devaraj NS. Attenuation of N-nitrosodiethylamine induced hepatocellular carcinogenesis by a novel flavonol-morin. Chemico biological Interaction, 2008, 171:79-88.

2.Kavitha D, Shilpa PN and Devaraj NS. Anti-bacterial effect of conessine, an alkaloid from Holarrhena antidysentrica against Enteropathogenic Escherichia coli. Biomedicine, 2003, 23: 66-71.

3.Kavitha D, Shilpa PN and Devaraj NS. Anti-bacterial and anti-diarrhoeal effects of alkaloids of Holarrhena antidysentrica WALL. Indian journal of experimental biology, 2004, 42: 589 –594.

4.Shilpa PN, Bavanilatha muthiah, Shaleesha Stanley and Wilson S. Antimicrobial effect of ethanolic extracts of Plumbago rosea and Plumbago zeylanica against Escherichia Coli & Proteus vulgaris isolated from UTI samples. Advanced Biotech, 2009.

5.Krishnamurrthi Genasan, Shilpa PN, and Kamarul T. Human amniotic membrane as a chondrocyte carrier vehicle/substrate: In vitro study. J Biomed Mater Res A, 2011, 99: 500-506.

6.Shilpa PN, Sivaramakrishnan V and Devaraj NS. Ameliorative effect of methanol extract of Rubia cordifolia in N-nitrosodiethylamine induced hepatocellular carcinoma. Pharmaceutical Biology, 2012, 50:376-83.

7.Shilpa PN, Sivaramakrishnan V and Devaraj NS. Induction of apoptosis by methanolic extract of Rubia Cordifolia Linn in HEp-2 Cell Line is mediated by reactive oxygen species. Asian Pacific Journal Cancer Prevention, 2012, 13: 2753-2758.

8.Jayshree Nellore, Cynthia Pauline, Kanchana Amarnath, and Shilpa PN. Antioxidant Effect of Gold Nanoparticles Synthesised from Curcuma Longa Restrains 1-Methyl-2-Phenyl Pyridinium Ion Induced Stress in PC12 Cells. Journal of Nanoneuroscience, 2012, 2: 63-74.

9.Lanka Shalini Reddy, Magar Nisha, Mary Joice, and Shilpa PN. Antimicrobial activity of zinc oxide (ZnO) nanoparticle against Klebsiella pneumonia. Pharmaceutical Biology, 2014, 15: 1-10

10.Shilpa PN, Devaraj NS and Sivaramakrishnan V. Rubia cordifolia mitigates experimental hepatocarcinogenesis by regulation MMP-2 and SPARC. International Journal of Pharmacy and Pharmaceutical Sciences, 2014, 6: 438-443.

11.Abbas AA, Mohamad JA, Lydia AL, Selvaratnam L, Razif A, Ab-Rahim S, Kavitha G, Shilpa PN, and Kamarul T. Autologous chondrocyte implantation for knee focal cartilage defects: 3Years follow-up at the University of Malaya Medical Centre. Journal of Health and Translational Medicine, 2014, 17:8-12.

Sequence Submitted to NCBI:

Bacillus cereus - KJ706217

Streptomyces coelicolor - KJ706218

Pseudomonas putida - KJ706219

Scientific abstracts presented at the symposia: (National and International)

1.Shilpa PN, Vaishnu Devi D and Devasenapathy A. Novel therapeutics for sepsis management. International Knowledge Millennium Conference, (IKMC 2014), Nov 3 & 4 2014, Hyderabad, India

2.Shilpa PN and Tunku Kamarul Zaman. Genetic Polymorphism Of CYP2C19 and CYPE1 enzyme in the Malaysian population: cigarette smoking and risk of COPD. 41st Malaysian Orthopaedic Association, Annual General Meeting/Annual Scientific Meeting & 5th ASEAN Arthroplasty Association Meeting, 22nd to 24thMay 2011, Kuala Lumpur, Malaysia.

3.Shilpa PN and Devaraj NS. Anti-invasive activity of Rubia cordifolia in Diethyl nitrosamine rats, Society for Free Radical Research (SFRR) India satellite meet in 2007, Kochi, India

4.Kavitha D, Shilpa PN and Devaraj NS. “Effect of Holarrena antidysentrica against Enteropathogenic Escherichia coli”, National Siddha Conference, 2002, Chennai, India.

Current/past Sponsored Research Projects:

Title of Project

Funding Agency

Amount

(Lakhs)

Period

Role

Affordable diagnostic immunochromatographic kit for gram positive bacterial sepsis

BIRAC – SPARSH

49.47

June 2015

PI



Contact this candidate